Multiple myeloma is a malignant disease of plasma cells that is characterised by secretion of paraprotein, humoral immunodeficiency, anaemia, lytic bone lesions, and kidney dysfunction. Although the median survival of patients with multiple myeloma has improved from seven months to five years with ...
The treatment of multiple myeloma (MM) continues to evolve rapidly with arrival of multiple new drugs, and emerging data from randomized trials to guide therapy. Along the disease course, the choice of specific therapy is affected by many variables including age, performance status, comorbidities, ...
George Nahas, DO, discusses ongoing research that may shape the future treatment landscape of multiple myeloma.
In spite of its reputation as a chemosensitive malignancy, multiple myeloma remains fatal for nearly all those who contract it. The mortality has changed little in the last 30 years (Feinleib & MacMahon, 1960), although the duration of the illness has been extended from a median of 7 ...
运输业者 (KUEHNE &有限公司NAGEL) 差错“通知党”,并且“托运人地址”在AWB,我仍然等待他们的修证本。 [translate] aNew Diagnostic Approaches and Treatment of Multiple Myeloma 多发性骨髓瘤的新的诊断方法和治疗 [translate] 英语翻译 日语翻译 韩语翻译 德语翻译 法语翻译 俄语翻译 阿拉伯语翻译 西班牙语翻译 ...
Recent Advances in the Treatment of Multiple Myeloma: Highlights from the ASH 2021 Meeting: Episode10 April 21, 2022 ByRafael Fonseca, MD Video A look at the unmet needs and future directions of multiple myeloma treatment. EP: 1.Triplet and Quadruplet Induction Regimens for Transplant-Eligible ...
The uniformly fatal plasma cell malignancy, multiple myeloma (MM), currently represents 10–15% of hematologic neoplasms in the USA and has been steadily increasing in incidence for several decades. Therapeutic alternatives have lagged significantly behind insights into the biology and pathogenesis of th...
Thirty-two patients with multiple myeloma were treated with recombinant alpha-interferon clone A (rIFN alpha A) daily by intramuscular injection with an initial dose of 12 X 10(6) U/m2. Of 27 patients evaluable for response, tumor responses were obtained in seven of 14 previously untreated ...
High-dose therapy and auto-SCT remain integral in the initial treatment of multiple myeloma (MM), and are increasingly being applied for management of relapsed disease. We examined the outcomes in 98 patients undergoing salvage auto-SCT (auto-SCT2) for relapsed MM after receiving an initial tran...
Molecular structure of Lenalidomide (Revlimid) - treatment of multiple myeloma ID:370470149 版权Raimundo79 TIFF大小 11.5MB 格式JPG 编辑图片 以图搜图 大图:2546×1573像素·21.56cm ×13.32cm·300dpi·JPG 中图:1000×618像素·35.28cm ×21.8cm·72dpi·JPG...